Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin In Vivo

Human Gene Therapy

Volumn 12, Issue 12, 2001, Pages 1527-1541

  Bartholomew, Amelia ^a   Patil, Sheila ^b   Mackay, Alastair ^b   Nelson, Mary ^a   Buyaner, Diana ^b   Hardy, Wayne ^b   Mosca, Joseph ^b   Sturgeon, Cord ^a   Siatskas, Mandy ^a   Mahmud, Nadim ^a   Ferrer, Karen ^a   Deans, Robert ^b   Moseley, Annemarie ^b   Hoffman, Ronald ^a   Devine, Steven M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b OSIRIS THERAPEUTICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GREEN FLUORESCENT PROTEIN; RETROVIRUS VECTOR;

ADIPOCYTE; ADULT; ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL POPULATION; CELL SHAPE; CONTROLLED STUDY; DEVICE; DNA MODIFICATION; FEMALE; GENE THERAPY; GENE TRANSFER; GENETIC CODE; GENETIC TRANSDUCTION; HEMATOCRIT; HUMAN; MALE; MESENCHYME; MOUSE; NONHUMAN; NORMAL HUMAN; OSTEOCYTE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; STEM CELL; TARGET CELL; TRANSGENE;

ADULT; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; ERYTHROPOIETIN; FEMALE; GENE THERAPY; GREEN FLUORESCENT PROTEINS; HEMATOCRIT; HUMANS; LUMINESCENT PROTEINS; MALE; MESODERM; MICE; MICE, SCID; MIDDLE AGED; MODELS, GENETIC; PAPIO; PHENOTYPE; RETROVIRIDAE; STEM CELLS; TIME FACTORS; TRANSDUCTION, GENETIC;

ANIMALIA; PAPIO; PAPIO HAMADRYAS; PRIMATES; UNIDENTIFIED RETROVIRUS;

EID: 0035574556     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340152480258     Document Type: Article

References (38)

1. LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors
2. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105)
3. Gene silencing as a threat to the success of gene therapy
4. Neovascularization of synthetic membranes directed by membrane microarchitecture
5. Transplantation of stromal cells transduced with the human IL3 gene to stimulate hematopoiesis in human fetal bone grafts in non-obese, diabetic-severe combined immunodeficiency mice
6. Mesenchymal stem cells
7. Transplantation of cells in an immunoisolation device for gene therapy
8. Bone marrow stromal cells as targets for gene therapy of hemophilia A
9. Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice
10. Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells
11. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion
12. Bone marrow stromal cells as a vehicle for gene transfer
13. Gene marking and gene therapy directed at primary hematopoietic cells
14. Transduction of hematopoietic stem cells in humans and in nonhuman primates
15. Novel retroviral packaging cell lines: Complementary tropisms and improved vector production for efficient gene transfer
16. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo
17. Gene therapy using hematopoietic stem cells: Sisyphus approaches the crest
18. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
19. Osteoblast-specific gene expression after transplantation of marrow cells: Implications for skeletal gene therapy
20. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells
21. A phase I study of the transplantation of genetically marked autologous bone marrow stromal cells
22. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor
23. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus
24. Plasma erythropoietin reference ranges in children
25. A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells
26. Recombinant human erythropoietin and autologous blood donation
27. Perioperative recombinant human erythropoietin
28. Treatment of acute postoperative anemia with recombinant human erythropoietin
29. Retroviral-mediated gene transfer into human bone marrow stromal cells: Studies of efficiency and in vivo survival in SCID mice
30. Multilineage potential of adult human mesenchymal stem cells
31. Marrow stromal cells as stem cells for non-hematopoietic tissues
32. Marrow stromal cells as stem cells for continual renewal of nonhematopoietic tissues and as potential vectors for gene therapy
33. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients
34. Effects of recombinant human erythropoietin and interleukin-3 on erythropoietic recovery from acute anemia
35. Enzymatic and functional correction along with long-term enzyme secretion from transduced bone marrow hematopoietic stem/progenitor and stromal cells derived from patients with Fabry disease
36. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability
37. Sustained correction of bleeding disorder in hemophilia B mice by gene therapy
38. Erythropoietin structure-function relationships: High degree of sequence homology among mammals